Financial Performance - The company's revenue for Q3 2023 reached ¥144,179,959.78, representing a year-on-year increase of 16.31%[5] - Net profit attributable to shareholders decreased by 35.79% to ¥36,523,483.46 for the quarter, and year-to-date net profit decreased by 22.68% to ¥128,155,346.50[5] - The basic earnings per share for Q3 2023 was ¥0.3044, down 35.78% compared to the same period last year[5] - The company reported total operating revenue of RMB 412,579,919.62 for the current period, an increase of 17% compared to RMB 352,578,259.34 in the previous period[25] - Operating profit for Q3 2023 was CNY 136,561,263.37, down from CNY 168,380,471.82 in the same period last year, reflecting a decline of 19%[26] - The net profit for Q3 2023 was CNY 120,139,318.92, a decrease of 25.5% compared to CNY 161,385,638.73 in Q3 2022[26] - The company reported a total comprehensive income of CNY 127,411,057.93 for Q3 2023, down from CNY 159,325,078.97 in the previous year[27] - Basic earnings per share for Q3 2023 were CNY 1.0680, compared to CNY 1.3813 in Q3 2022, reflecting a decrease of 22.6%[27] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,793,150,260.41, reflecting a 2.09% increase from the end of the previous year[9] - As of September 30, 2023, the company's total assets reached RMB 2,793,150,260.41, compared to RMB 2,735,960,236.60 at the beginning of the year[23] - The company's total liabilities amounted to RMB 208,189,343.96, up from RMB 167,253,156.96 in the previous period[23] - The total equity attributable to shareholders reached RMB 2,587,474,293.13, compared to RMB 2,563,204,428.74 at the beginning of the year[23] Cash Flow - Cash flow from operating activities for the year-to-date period was ¥66,212,020.24, down 45.15% compared to the previous year[5] - The cash flow from operating activities was CNY 66,212,020.24, a decrease of 45% compared to CNY 120,725,362.57 in Q3 2022[30] - The company experienced a net cash outflow from investing activities of CNY -77,610,774.77, compared to CNY -1,092,287,989.20 in the same period last year[30] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 11,705[11] - The top ten unrestricted shareholders hold a total of 22,000,000 shares, with the largest shareholder being the National Social Security Fund holding 5,084,491 shares[12] - The company reported a total of 57,154,870 restricted shares at the end of the period, with 19,051,623 shares added during the current period[14] - The company has a total of 38,110,747 restricted shares at the beginning of the period, with 7,500 shares released during the current period[14] - The company has a total of 10,707,678 restricted shares held by Miao Jingyun, which will also be released on October 18, 2024[14] Incentive Plans - The company held a meeting on September 15, 2023, to approve the 2023 Restricted Stock Incentive Plan, which includes management assessment methods and the list of incentive recipients[15] - The company announced that no objections were raised during the public notice period for the incentive recipients from September 16 to September 25, 2023[16] - The company held a second extraordinary general meeting on October 9, 2023, to approve the 2023 Restricted Stock Incentive Plan and related matters[17] - The company’s stock incentive plan is aimed at enhancing employee motivation and aligning their interests with shareholders[15] Business Growth - The company reported a 30% year-on-year increase in regular business sales revenue, excluding specific products related to acute respiratory infectious diseases[5] - The company’s overseas regular business saw a growth of over 40% year-on-year[5] Expenses - Total operating costs amounted to RMB 263,538,539.54, up from RMB 195,778,143.54 in the previous period, reflecting a significant increase in expenses[25] - Research and development expenses for Q3 2023 amounted to CNY 94,032,450.46, up from CNY 87,747,814.31, indicating an increase of 7.3% year-over-year[26]
百普赛斯(301080) - 2023 Q3 - 季度财报